Yew Bio-Pharm Group, Inc. (YEWB) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Yew Bio-Pharm Group, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
3.67
Strong
WeakModerateStrong
P/B Ratio
0.13
Strong
WeakModerateStrong
Earnings Yield
25.76%
Strong
WeakModerateStrong
Profitability Health
2020Return on Equity
3.22%
Weak
WeakModerateStrong
Operating Margin
9.41%
Weak
WeakModerateStrong
Net Profit Margin
5.36%
Weak
WeakModerateStrong
Growth Indicators
2020Revenue Growth
-2.07%
Weak
WeakModerateStrong
Net Income Growth
48.64%
Strong
WeakModerateStrong
EPS Growth
50.00%
Strong
WeakModerateStrong
Efficiency & Liquidity
2020Current Ratio
0.95
Weak
WeakModerateStrong
Quick Ratio
0.95
Weak
WeakModerateStrong
Asset Turnover
0.47x
Weak
WeakModerateStrong
Inventory Turnover
1627.92x
Strong
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-0.28%
Weak
WeakModerateStrong
EV / Free Cash Flow
-903.19x
Strong
WeakModerateStrong
Net Debt / EBITDA
1.84x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.581
Weak
WeakModerateStrong
Return on Invested Capital
4.42%
Weak
WeakModerateStrong
Cash Conversion Cycle
-3.37 days
Strong
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for YEWB.
View Financial Statements